217 related articles for article (PubMed ID: 34418761)
21. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
22. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
[TBL] [Abstract][Full Text] [Related]
23. Early detection of Alzheimer's disease with a total score of the German CERAD.
Ehrensperger MM; Berres M; Taylor KI; Monsch AU
J Int Neuropsychol Soc; 2010 Sep; 16(5):910-20. PubMed ID: 20682088
[TBL] [Abstract][Full Text] [Related]
24. A normative study of total scores of the CERAD neuropsychological assessment battery in an educationally diverse elderly population.
Han JY; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Choi HJ; Kim SG; Park SY; Kim JW; Youn JC; Jhoo JH; Lee JH; Kim KW; Woo JI; Lee DY
Int Psychogeriatr; 2014 Nov; 26(11):1897-904. PubMed ID: 25075438
[TBL] [Abstract][Full Text] [Related]
25. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.
Poletti M; Frosini D; Pagni C; Baldacci F; Nicoletti V; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):601-6. PubMed ID: 22492216
[TBL] [Abstract][Full Text] [Related]
26. [Screening of executive functions in patients with Parkinson's disease using the new rapid test PAL-5].
Scheffels JF; Engels JE; Kalbe E; Kessler J
Fortschr Neurol Psychiatr; 2018 Apr; 86(4):219-225. PubMed ID: 29186725
[TBL] [Abstract][Full Text] [Related]
27. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases.
Hessen E; Stav AL; Auning E; Selnes P; Blomsø L; Holmeide CE; Johansen KK; Eliassen CF; Reinvang I; Fladby T; Aarsland D
J Parkinsons Dis; 2016 Apr; 6(2):413-21. PubMed ID: 27061068
[TBL] [Abstract][Full Text] [Related]
29. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
[TBL] [Abstract][Full Text] [Related]
30. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
[TBL] [Abstract][Full Text] [Related]
32. Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.
Wojtala J; Heber IA; Neuser P; Heller J; Kalbe E; Rehberg SP; Storch A; Linse K; Schneider C; Gräber S; Berg D; Dams J; Balzer-Geldsetzer M; Hilker-Roggendorf R; Oberschmidt C; Baudrexel S; Witt K; Schmidt N; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Spottke A; Roeske S; Wüllner U; Wittchen HU; Riedel O; Dodel R; Schulz JB; Reetz K
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):171-179. PubMed ID: 30297519
[TBL] [Abstract][Full Text] [Related]
33. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
[TBL] [Abstract][Full Text] [Related]
34. Clinical validity of the Mattis Dementia Rating Scale in differentiating mild cognitive impairment in Parkinson's disease and normative data.
Bezdicek O; Michalec J; Nikolai T; Havránková P; Roth J; Jech R; Růžička E
Dement Geriatr Cogn Disord; 2015; 39(5-6):303-11. PubMed ID: 25792240
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
[TBL] [Abstract][Full Text] [Related]
36. The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
Stein J; Luppa M; Luck T; Maier W; Wagner M; Daerr M; van den Bussche H; Zimmermann T; Köhler M; Bickel H; Mösch E; Weyerer S; Kaufeler T; Pentzek M; Wiese B; Wollny A; König HH; Riedel-Heller SG
Am J Geriatr Psychiatry; 2012 Jan; 20(1):84-97. PubMed ID: 22183013
[TBL] [Abstract][Full Text] [Related]
37. The CERAD Neuropsychological Assessment Battery Is Sensitive to Alcohol-Related Cognitive Deficiencies in Elderly Patients: A Retrospective Matched Case-Control Study.
Kaufmann L; Huber S; Mayer D; Moeller K; Marksteiner J
J Int Neuropsychol Soc; 2018 Apr; 24(4):360-371. PubMed ID: 29103404
[TBL] [Abstract][Full Text] [Related]
38. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
[TBL] [Abstract][Full Text] [Related]
39. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
[TBL] [Abstract][Full Text] [Related]
40. Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.
Fengler S; Kessler J; Timmermann L; Zapf A; Elben S; Wojtecki L; Tucha O; Kalbe E
PLoS One; 2016; 11(7):e0159318. PubMed ID: 27437705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
